Ovarian Insufficiency: From Molecular Pathology to Novel Therapeutic Approach
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 1
Special Issue Editor
2. Academy of Sciences and Arts of Bosnia and Herzegovina, 71000 Sarajevo, Bosnia and Herzegovina
3. Medigroup Health System, Dubrovnik International University, 20000 Dubrovnik, Croatia
Interests: dual-double stem cell
Special Issue Information
Dear Colleagues,
Ovarian insufficiency represents a challenge where recent molecular discoveries revolutionized our understanding and therapeutic arsenal.
Recent molecular insights have revealed intricate mechanisms beyond traditional paradigms. Epigenetic modifications, particularly DNA methylation and histone acetylation, regulate follicular dynamics and ovarian aging. Mitochondrial dysfunction emerges as a central player in oocyte quality deterioration, while inflammasome activation and oxidative stress accelerate follicular atresia. Ovarian stem cell discovery challenges conventional dogma, and cellular senescence pathways offer therapeutic targets.
While conventional approaches—hormone replacement therapy and assisted reproductive technologies—remain foundational, emerging interventions are transforming clinical possibilities. Intraovarian regenerative therapies include platelet-rich plasma, mesenchymal and very small embryonic-like stem cells, and bioengineered ovarian tissue reconstruction. Growth hormone supplementation, mitochondrial-targeted antioxidants, NAD+ precursors, and senolytic agents address cellular senescence. Advanced techniques—in vitro maturation with stem cell co-culture, in vitro gametogenesis, and three-dimensional ovarian scaffolds—represent paradigm-shifting approaches targeting fundamental mechanisms of ovarian decline.
This Special Issue welcomes research elucidating molecular mechanisms—genetic, immunological, and metabolic—and clinical investigations of both established and experimental therapies. We seek studies that translate laboratory discoveries into evidence-based protocols, offering tangible hope for women with premature ovarian insufficiency, diminished reserve, and age-related dysfunction.
Together, we advance precision medicine in reproductive health.
Prof. Dr. Aleksandar Ljubić
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian insufficiency
- premature ovarian insufficiency
- molecular pathology
- regenerative medicine
- stem cell therapy
- platelet-rich plasma
- epigenetics
- intraovarian treatment
- ovarian stem cells
- mitochondrial dysfunction
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
